Debasis Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Debasis Das has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
Manish Kumar Sharma
Narayana Superspeciality Hospital - Howrah
14 shared publications- Shubhadeep Das
Narayana Superspeciality Hospital - Howrah
12 shared publications Amitabha Chattopadhyay
Department of Pediatric Cardiology, Narayana Superspeciality Hospital, Howrah, West Bengal, India
11 shared publicationsNilanjan Dutta
Narayana Superspeciality Hospital
11 shared publicationsShubhadeep Das
Department of Pediatric Cardiac Intensive Care, Narayana Superspeciality Hospital, Kolkata, West Bengal, India
11 shared publicationsShivani Gajpal
Narayana Superspeciality Hospital - Howrah
10 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (6) , 625-627
From survival to lifetime management: The evolving journey of congenital heart disease
Was not provided for this article.
- 16 November 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (6) , 625-627
Open AccessFrom survival to lifetime management: The evolving journey of congenital heart disease
Was not provided for this article.
- 5 November 2026
- Published by Wiley in Transplant Infectious Disease
- p. e70353
Indian Society of Organ Transplantation Consensus Recommendations on Latent Tuberculosis in Kidney Transplantation
Background: Tuberculosis remains a principal cause of morbidity and mortality after kidney transplantation across South and Southeast Asia, where tuberculosis infection is prevalent. India carries one‐quarter of the global tuberculosis burden, yet transplant‐specific guidance for high‐burden settings is scarce. The Indian Society of Organ Transplantation (ISOT) convened a multidisciplinary expert panel to formulate consensus recommendations for the management of tuberculosis infection in kidney transplantation. Methods: A multidisciplinary panel undertook a structured, evidence‐informed consensus process, appraising MEDLINE, EMBASE, Scopus, the Cochrane Library, and national tuberculosis program documents. Statements were refined through successive revision rounds, panel discussion at the ISOT Mid‐Term Conference (Bengaluru, May 2026), and confirmation by all authors, preceding executive committee endorsement. Each statement received an evidence level (1–5) and, where actionable, a recommendation strength. Results: The panel formulated 36 consensus statements across 11 domains. Routine pre‐transplant screening for tuberculosis infection is endorsed, with exclusion of tuberculosis disease before treatment of tuberculosis infection. The interferon‐gamma release assay (IGRA) is preferred, given confounding of the tuberculin skin test by bacille Calmette–Guérin (BCG) vaccination; a Mycobacterium tuberculosis ‐specific antigen‐based skin test (Cy‐Tb) is an acceptable alternative where IGRA is unavailable or unaffordable. Isoniazid‐based regimens are preferred, as rifampicin reduces calcineurin‐inhibitor exposure; isoniazid resistance, hepatotoxicity, and hepatitis C co‐infection warrant individualized therapy. Conclusion: This first India‐specific, society‐endorsed position statement provides context‐adapted recommendations for the management of tuberculosis infection in kidney transplantation and may inform adaptation in other high‐burden settings; prospective multicenter studies are needed. image
- 5 November 2026
- Published by Wiley in Transplant Infectious Disease
- p. e70353
Indian Society of Organ Transplantation Consensus Recommendations on Latent Tuberculosis in Kidney Transplantation
Background: Tuberculosis remains a principal cause of morbidity and mortality after kidney transplantation across South and Southeast Asia, where tuberculosis infection is prevalent. India carries one‐quarter of the global tuberculosis burden, yet transplant‐specific guidance for high‐burden settings is scarce. The Indian Society of Organ Transplantation (ISOT) convened a multidisciplinary expert panel to formulate consensus recommendations for the management of tuberculosis infection in kidney transplantation. Methods: A multidisciplinary panel undertook a structured, evidence‐informed consensus process, appraising MEDLINE, EMBASE, Scopus, the Cochrane Library, and national tuberculosis program documents. Statements were refined through successive revision rounds, panel discussion at the ISOT Mid‐Term Conference (Bengaluru, May 2026), and confirmation by all authors, preceding executive committee endorsement. Each statement received an evidence level (1–5) and, where actionable, a recommendation strength. Results: The panel formulated 36 consensus statements across 11 domains. Routine pre‐transplant screening for tuberculosis infection is endorsed, with exclusion of tuberculosis disease before treatment of tuberculosis infection. The interferon‐gamma release assay (IGRA) is preferred, given confounding of the tuberculin skin test by bacille Calmette–Guérin (BCG) vaccination; a Mycobacterium tuberculosis ‐specific antigen‐based skin test (Cy‐Tb) is an acceptable alternative where IGRA is unavailable or unaffordable. Isoniazid‐based regimens are preferred, as rifampicin reduces calcineurin‐inhibitor exposure; isoniazid resistance, hepatotoxicity, and hepatitis C co‐infection warrant individualized therapy. Conclusion: This first India‐specific, society‐endorsed position statement provides context‐adapted recommendations for the management of tuberculosis infection in kidney transplantation and may inform adaptation in other high‐burden settings; prospective multicenter studies are needed. image
- 30 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (10) , 2127-2132
Analysis of early surgical outcomes in adolescent and adult patients undergoing repair for tetralogy of Fallot
Background: Tetralogy of Fallot is the most common cyanotic CHD and is ideally repaired during infancy. However, delayed diagnosis and limited access to congenital cardiac care may result in presentation during adolescence or adulthood. This study evaluated outcomes of tetralogy of Fallot repair in patients aged ≥ 13 years. Patients and Methods: This retrospective cohort study included patients aged ≥ 13 years undergoing primary tetralogy of Fallot repair between June 2016 and June 2025. Demographic, operative, and post-operative data, including early mortality and reintervention, were analysed. Results: Ninety-four patients underwent repair at a median age of 15 years (interquartile range: 3) and weight of 36.5 kg (interquartile range: 12.2). Pre-operative coil embolisation of aortopulmonary collaterals was required in 26.6%. Mean cardiopulmonary bypass and aortic cross-clamp times were 114.8 ± 49.8 and 82.4 ± 35.6 minutes, respectively. Mean ventilation duration was 7.7 ± 7.1 hours, ICU stay 3.9 ± 1.0 days, and post-operative hospital stay 4.6 ± 1.3 days. Transannular patch repair was performed in 65 patients (69%), while 29 (31%) underwent pulmonary valve-preserving repair, with comparable early outcomes. Thirty-day mortality was 1.06%, and reintervention occurred in 2.1% during a mean follow-up of 38.4 months. Conclusions: Primary repair of tetralogy of Fallot in late-presenting adolescents and adults can be performed with low early mortality and acceptable morbidity. Careful pre-operative assessment, including identification and management of significant aortopulmonary collaterals, and individualised right ventricular outflow tract reconstruction are important components of management. These findings support definitive repair in appropriately selected late-presenting patients.
- 30 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (10) , 2127-2132
Analysis of early surgical outcomes in adolescent and adult patients undergoing repair for tetralogy of Fallot
Background: Tetralogy of Fallot is the most common cyanotic CHD and is ideally repaired during infancy. However, delayed diagnosis and limited access to congenital cardiac care may result in presentation during adolescence or adulthood. This study evaluated outcomes of tetralogy of Fallot repair in patients aged ≥ 13 years. Patients and Methods: This retrospective cohort study included patients aged ≥ 13 years undergoing primary tetralogy of Fallot repair between June 2016 and June 2025. Demographic, operative, and post-operative data, including early mortality and reintervention, were analysed. Results: Ninety-four patients underwent repair at a median age of 15 years (interquartile range: 3) and weight of 36.5 kg (interquartile range: 12.2). Pre-operative coil embolisation of aortopulmonary collaterals was required in 26.6%. Mean cardiopulmonary bypass and aortic cross-clamp times were 114.8 ± 49.8 and 82.4 ± 35.6 minutes, respectively. Mean ventilation duration was 7.7 ± 7.1 hours, ICU stay 3.9 ± 1.0 days, and post-operative hospital stay 4.6 ± 1.3 days. Transannular patch repair was performed in 65 patients (69%), while 29 (31%) underwent pulmonary valve-preserving repair, with comparable early outcomes. Thirty-day mortality was 1.06%, and reintervention occurred in 2.1% during a mean follow-up of 38.4 months. Conclusions: Primary repair of tetralogy of Fallot in late-presenting adolescents and adults can be performed with low early mortality and acceptable morbidity. Careful pre-operative assessment, including identification and management of significant aortopulmonary collaterals, and individualised right ventricular outflow tract reconstruction are important components of management. These findings support definitive repair in appropriately selected late-presenting patients.
- Open Access
- 8 October 2026
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
Operational guidelines for kidney swap transplantation in India: an ISOT-NOTTO Delphi consensus
- 8 October 2026
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
Open AccessOperational guidelines for kidney swap transplantation in India: an ISOT-NOTTO Delphi consensus
- Open Access
- 8 September 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (5) , 463-465
The geography of congenital heart disease care: Is the world flat?
Was not provided for this article.
- 8 September 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (5) , 463-465
Open AccessThe geography of congenital heart disease care: Is the world flat?
Was not provided for this article.
- Open Access
- 31 July 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (4) , 361-363
Beyond case reports: Moving toward high-quality, practice-changing, contextual research in congenital heart disease
Was not provided for this article.
- 31 July 2026
- Published by Wolters Kluwer Health in Annals of Pediatric Cardiology
- Vol. 19 (4) , 361-363
Open AccessBeyond case reports: Moving toward high-quality, practice-changing, contextual research in congenital heart disease
Was not provided for this article.
- 20 May 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (6) , 834-842
Quality Improvement in Congenital Heart Surgery Requires Data: Is This Asking too Much in Low- and Middle-Income Countries?
Quality improvement (QI) in congenital heart surgery depends mainly on the availability of reliable, organized, and usable data. While high-income countries benefit from mature national registries and well-established benchmarking systems, low- and middle-income countries (LMICs), which carry the largest global burden of congenital heart disease, continue to face significant challenges in data collection. This narrative review examines the current evolving data landscape for congenital heart surgery in LMICs, explores the relationship between existence of data systems and QI, identifies persistent barriers to data collection, and proposes context-appropriate strategies for sustainable progress. Evidence from published outcome studies, national and regional registry reports, and some major international databases demonstrates encouraging growth in progressive maturation of data systems across LMICs. Importantly, successful models illustrate that even incremental data collection, when focused on high-impact indicators such as mortality, major morbidity, and hospital length of stay, can generate meaningful improvements when linked with local clinical leadership, simple audit mechanisms, and collaborative learning networks. Although comprehensive, high-fidelity data collection may be unrealistic in many resource-constrained environments, the pursuit of perfection should not impede progress. Stepwise, local data strategies, supported by international collaboration, capacity building, and context-sensitive implementation, offer a realistic and transformative pathway toward safer, more equitable congenital cardiac care in LMICs.
- 20 May 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (6) , 834-842
Quality Improvement in Congenital Heart Surgery Requires Data: Is This Asking too Much in Low- and Middle-Income Countries?
Quality improvement (QI) in congenital heart surgery depends mainly on the availability of reliable, organized, and usable data. While high-income countries benefit from mature national registries and well-established benchmarking systems, low- and middle-income countries (LMICs), which carry the largest global burden of congenital heart disease, continue to face significant challenges in data collection. This narrative review examines the current evolving data landscape for congenital heart surgery in LMICs, explores the relationship between existence of data systems and QI, identifies persistent barriers to data collection, and proposes context-appropriate strategies for sustainable progress. Evidence from published outcome studies, national and regional registry reports, and some major international databases demonstrates encouraging growth in progressive maturation of data systems across LMICs. Importantly, successful models illustrate that even incremental data collection, when focused on high-impact indicators such as mortality, major morbidity, and hospital length of stay, can generate meaningful improvements when linked with local clinical leadership, simple audit mechanisms, and collaborative learning networks. Although comprehensive, high-fidelity data collection may be unrealistic in many resource-constrained environments, the pursuit of perfection should not impede progress. Stepwise, local data strategies, supported by international collaboration, capacity building, and context-sensitive implementation, offer a realistic and transformative pathway toward safer, more equitable congenital cardiac care in LMICs.
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Journal of the Practice of Cardiovascular Sciences
- Vol. 12 (2) , 185-187
Late Explantation of a Starr‐Edwards Caged‐ball Mitral Valve Prosthesis
Mechanical mitral valve (MV) prostheses have evolved considerably over the past few decades, with early designs still being seen in patients because of their proven durability. Although these early-generation valves like the caged-ball prosthesis demonstrated remarkable longevity, their long-term use was eventually limited by the risk of thromboembolic complications and gradual development of gradients due to pannus formation. Despite discontinuation of their manufacture, such valves continue to be encountered in current clinical practice due to their extensive historical implantation. In this report, we discuss a case of a 30-year-old female who underwent an MV replacement with a Starr-Edwards (SE) caged-ball valve prosthesis 15 years back and had now come with a significant gradient. This case highlights the durability of the SE valve and how the need for later replacement is not due to a structural issue of the valve.
- 1 May 2026
- Published by Wolters Kluwer Health in Journal of the Practice of Cardiovascular Sciences
- Vol. 12 (2) , 185-187
Open AccessLate Explantation of a Starr‐Edwards Caged‐ball Mitral Valve Prosthesis
Mechanical mitral valve (MV) prostheses have evolved considerably over the past few decades, with early designs still being seen in patients because of their proven durability. Although these early-generation valves like the caged-ball prosthesis demonstrated remarkable longevity, their long-term use was eventually limited by the risk of thromboembolic complications and gradual development of gradients due to pannus formation. Despite discontinuation of their manufacture, such valves continue to be encountered in current clinical practice due to their extensive historical implantation. In this report, we discuss a case of a 30-year-old female who underwent an MV replacement with a Starr-Edwards (SE) caged-ball valve prosthesis 15 years back and had now come with a significant gradient. This case highlights the durability of the SE valve and how the need for later replacement is not due to a structural issue of the valve.
- 30 April 2026
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 42 (7) , 844-846
Size compatibility in pediatric heart transplantation: impact on outcomes
Donor–recipient size mismatch in pediatric heart transplantation remains a clinically important and frequently debated issue, with significant implications for donor utilization and outcomes. In this context, the authors Ganduboina et al. provide a thoughtful analysis of the impact of size mismatch, stratified into graded categories and further delineated into undersizing and oversizing. Oversizing, which is considerably more common in contemporary practice, was not associated with adverse outcomes across short-, mid-, or long-term survival, reinforcing the growing acceptance of liberal size-matching strategies. In contrast, undersizing was associated with reduced mid-term survival; however, this relationship did not persist after adjustment for confounding variables, suggesting that recipient and perioperative factors may play a more dominant role than size mismatch alone. These observations align with evolving clinical practice, where oversized grafts are often preferentially used in higher-risk recipients to provide physiological reserve. At the same time, the study underscores the need to interpret size mismatch within a broader clinical context, rather than as an isolated determinant of outcome. Collectively, these findings support a more flexible, individualized approach to donor selection while highlighting areas for future refinement.
- 30 April 2026
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 42 (7) , 844-846
Size compatibility in pediatric heart transplantation: impact on outcomes
Donor–recipient size mismatch in pediatric heart transplantation remains a clinically important and frequently debated issue, with significant implications for donor utilization and outcomes. In this context, the authors Ganduboina et al. provide a thoughtful analysis of the impact of size mismatch, stratified into graded categories and further delineated into undersizing and oversizing. Oversizing, which is considerably more common in contemporary practice, was not associated with adverse outcomes across short-, mid-, or long-term survival, reinforcing the growing acceptance of liberal size-matching strategies. In contrast, undersizing was associated with reduced mid-term survival; however, this relationship did not persist after adjustment for confounding variables, suggesting that recipient and perioperative factors may play a more dominant role than size mismatch alone. These observations align with evolving clinical practice, where oversized grafts are often preferentially used in higher-risk recipients to provide physiological reserve. At the same time, the study underscores the need to interpret size mismatch within a broader clinical context, rather than as an isolated determinant of outcome. Collectively, these findings support a more flexible, individualized approach to donor selection while highlighting areas for future refinement.
- 13 April 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (4) , 663-667
Prospective observational study comparing the outcomes of fenestrated and non-fenestrated extracardiac Fontan procedure
Background: Fenestration in the Fontan procedure was introduced to improve early postoperative outcomes by reducing systemic venous pressure and augmenting preload to the systemic ventricle. It is believed to decrease pleural drainage, shorten hospital stay, and reduce complications. However, fenestration may result in systemic desaturation and carries a potential risk of paradoxical thromboembolism. The benefits of routine fenestration remain controversial. This study aimed to evaluate whether adding a fenestration influences early postoperative outcomes. Patients and methods: Between March 2024 and November 2025, 52 patients underwent Fontan completion at our institution. Forty patients met the inclusion criteria and were prospectively divided into two equal groups: non-fenestrated (Group 1, n = 20) and fenestrated (Group 2, n = 20). Twelve patients were excluded due to a primary Fontan procedure, elevated pulmonary vascular resistance, increased transpulmonary gradient, or significant branch pulmonary artery distortion. Demographic and perioperative parameters, including ventilation duration, inotrope duration, chest drain duration and volume, ICU stay, and total hospital stay, were analysed. Results: Baseline demographic and intraoperative variables were comparable between groups. Duration of mechanical ventilation, ICU stay, total chest drainage, and cardiopulmonary bypass time were similar. Chest drain duration was shorter in the fenestrated group (8.1 ± 4.2 vs. 10.2 ± 5.3 days), but this difference was not statistically significant ( p = 0.173). Discharge oxygen saturation was significantly lower in the fenestrated group (88.9 ± 5.6% vs. 93.3 ± 3.5%; p = 0.0072). Conclusion: In the present cohort, fenestration was not associated with a statistically significant improvement in most early perioperative outcomes. Larger studies are needed to define its role.
- 13 April 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (4) , 663-667
Prospective observational study comparing the outcomes of fenestrated and non-fenestrated extracardiac Fontan procedure
Background: Fenestration in the Fontan procedure was introduced to improve early postoperative outcomes by reducing systemic venous pressure and augmenting preload to the systemic ventricle. It is believed to decrease pleural drainage, shorten hospital stay, and reduce complications. However, fenestration may result in systemic desaturation and carries a potential risk of paradoxical thromboembolism. The benefits of routine fenestration remain controversial. This study aimed to evaluate whether adding a fenestration influences early postoperative outcomes. Patients and methods: Between March 2024 and November 2025, 52 patients underwent Fontan completion at our institution. Forty patients met the inclusion criteria and were prospectively divided into two equal groups: non-fenestrated (Group 1, n = 20) and fenestrated (Group 2, n = 20). Twelve patients were excluded due to a primary Fontan procedure, elevated pulmonary vascular resistance, increased transpulmonary gradient, or significant branch pulmonary artery distortion. Demographic and perioperative parameters, including ventilation duration, inotrope duration, chest drain duration and volume, ICU stay, and total hospital stay, were analysed. Results: Baseline demographic and intraoperative variables were comparable between groups. Duration of mechanical ventilation, ICU stay, total chest drainage, and cardiopulmonary bypass time were similar. Chest drain duration was shorter in the fenestrated group (8.1 ± 4.2 vs. 10.2 ± 5.3 days), but this difference was not statistically significant ( p = 0.173). Discharge oxygen saturation was significantly lower in the fenestrated group (88.9 ± 5.6% vs. 93.3 ± 3.5%; p = 0.0072). Conclusion: In the present cohort, fenestration was not associated with a statistically significant improvement in most early perioperative outcomes. Larger studies are needed to define its role.